Clinical Trial Update: A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease [Phase 1]

View source ↗

Summary

This is a first-in-human Phase 1 study of LY3954068 in adults with early symptomatic Alzheimer's disease, and it is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• LY3954068 (LY3954068)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Alzheimer Disease | Phase 1 | Status: RECRUITING